next A call from federal health agenciesMore than 40 states quickly suspended or recommended that Johnson & Johnson vaccine providers be paused after six women in the United States developed a rare blood clot-related disorder within one to three weeks of vaccination.
Countries Include: AlabamaAnd the CaliforniaAnd the ColoradoAnd the ConnecticutAnd the DelawareAnd the FloridaAnd the GeorgiaAnd the IdahoAnd the IllinoisAnd the IndianaAnd the YesAnd the KSAnd the KentuckyAnd the LouisianaAnd the whoAnd the MarylandAnd the MassachusettsAnd the MichiganAnd the MinnesotaAnd the MississippiAnd the MissouriAnd the New JerseyAnd the New MexicoAnd the NebraskaAnd the New YorkAnd the North CarolinaAnd the OhioAnd the OklahomaAnd the OregonAnd the PennsylvaniaAnd the Rhode IslandAnd the South CarolinaAnd the South DakotaAnd the TennesseeAnd the TexasAnd the UtahAnd the VermontAnd the VirginiaAnd the Washington StateAnd the West Virginia And the Wisconsin.
CVS and Walgreens, the nation’s largest retail pharmacy chain, said they will immediately stop Johnson & Johnson vaccinations. The two companies said they have been emailing clients whose appointments will be canceled and will reschedule appointments when possible.
Publix and Wegmans, two large supermarket chains in the United States, have also announced that they will be suspending use of this vaccine. Wigmans said It will cancel all appointments for the Johnson & Johnson vaccine, but will continue to offer Moderna and Pfizer-BioNTech doses as they become available, and Publix said Clients can schedule Moderna vaccine online.
Gov. Mike DeWine Ohio The state’s chief health official said they are advising all state vaccine providers to temporarily stop using the single-dose vaccine. Connecticut health officials said they are He asked the vaccine providers to delay the scheduled appointments Or give an alternate option if they have the supply. New York Health Commissioner Dr. Howard Zucker said the state will stop using the Johnson & Johnson vaccine while the Food and Drug Administration and the Centers for Disease Control and Prevention are assessing safety risks. Dr. Zucker said Tuesday’s Johnson & Johnson appointments at state public sites will be honored with Pfizer doses.
Dr. Erica Pan, California’s chief epidemiologist, said the state will follow federal guidelines and direct health care providers to temporarily stop vaccine administration, “until we receive further guidance from health and safety experts.”
The The California temporary moratorium comes just a day before the state is set to expand eligibility to anyone 16 years of age or older – a step Some experts worried It will lead to frustration, as the explosion in dosage demand coincides with a drop in supply and strains an already confusing mix of prescribing systems. There were questions on the horizon about how long the temporary halt would last, as well as whether the slowdown in supply would affect the country’s plans to reopen.
Governor Gavin Newsom said on Twitter that the state is vaccinating more than 3 million people per week, and that the state is “Still on track to fully reopen” on June 15thBut the plan depends on a large scale Access to vaccinations.
The White House said on Tuesday that the halt would not have a major impact on the nation’s vaccination campaign, which has accelerated in recent weeks as a spike in new virus cases threatens a fourth potential increase. Many countries have already been conquered Eligibility for vaccination For all adults and others plan by next week.
“Over the past few weeks, we’ve provided more than 25 million doses of Pfizer and Moderna every week, and in fact this week we’re going to provide 28 million doses of these vaccines,” Jeff Zentes, The White House Coordinated Covid-19 Response, Tuesday. “This is more than enough supplies to continue the current pace of vaccinations of 3 million shots a day.”
As of Monday, 36 percent of the country’s total population has received at least one injection of the vaccine, and 22 percent have been fully vaccinated. According to data from the CDC
Although reaction to the Johnson & Johnson injection is rare, any questions about the safety of the shots can reinforce hesitation about the vaccine.
Nearly seven million people in the United States have received shots from Johnson & Johnson to date, and nearly nine million more doses have been shipped to the states, according to data from the Center for Disease Control and Prevention. Between 18 years old. 48. A woman died and another woman was hospitalized in Nebraska in critical condition.
“We recommend that this vaccine be discontinued out of great caution,” said Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biological Assessment and Research, and Dr. Anne Schuchat, deputy director of the CDC, said. In a joint statement. “At the moment, these negative events appear to be extremely rare.”
At a press conference later Tuesday morning, Dr. Marks said that “on an individual basis, the provider and the patient can decide whether or not to receive the vaccine” produced by Johnson & Johnson.
The Centers for Disease Control and Prevention’s external advisory committee of independent experts designated an emergency meeting on Wednesday.
Experts have not yet determined to what extent, if any, the vaccine is responsible for the clots. But the investigation follows actions by European regulators who have concluded that a vaccine produced by AstraZeneca may also be a cause of a similar and extremely rare clotting disorder.
Public health experts in the United States and Europe have confirmed that for most people, the benefits of Covid-19 vaccines far outweigh the risks. Fewer than one in a million Johnson & Johnson vaccines is now under investigation. If there is indeed a risk of blood clots developing from the vaccine – which has yet to be determined – this risk is very low. The risk of contracting Covid-19 in the United States is much higher.
FDA Recommend People who have received the Johnson & Johnson vaccine within the past three weeks should contact their doctors if they experience severe headache, abdominal pain, leg pain, or shortness of breath. People should not be concerned about mild headaches and flu-like symptoms for the first few days after vaccination. These are a common, harmless side effect caused by the immune system producing a defense against the Coronavirus.
Federal officials are concerned that doctors may not be trained to look for the rare disorder if vaccine recipients develop symptoms. “The treatment for this specific type of blood clot is different from the treatment that would normally be given” for blood clots, federal health agencies said Tuesday morning.
Usually, an anticoagulant drug called heparin is used to treat blood clots. In this situation, taking heparin may be dangerous, and alternative treatments must be given.
Like many countries, New York had already braced for a major drop In supplying Johnson & Johnson vaccine after federal officials said supplies will be limited due to a production problem at the Baltimore manufacturing plant. On Friday, Governor Andrew M. Cuomo said New York expects to receive 34,900 injections of Johnson & Johnson, an 88 percent decrease from the previous week.
Dr. Zucker, New York’s health commissioner, said the state will honor appointments made at state-run mass vaccination sites for the Johnson & Johnson vaccine by giving people the Pfizer-BioNTech vaccine instead. At a press conference, Mr Cuomo said the country has sufficient supplies of Pfizer and Moderna vaccines to be able to stick to the current vaccination pace.
New York City Mayor Bill de Blasio said the city will work with its vaccination sites to help people get their Pfizer or Moderna vaccine appointments instead.
“This morning every site has been told to stop giving J&J footage,” he said at a press conference.
Mr. Como and Mr. de Blasio received the Johnson & Johnson vaccine in two separate appearances last month, which they framed as an effort to boost confidence in it. The vaccine efficacy rate To treat vaccine frequency.
City Health Commissioner, Dr. Dave Chukchi, said that about 234,000 residents have received the Johnson & Johnson vaccine and none have reported any blood clots so far. The city has been relying on the vaccine to vaccinate hard-to-reach New Yorkers, including People who are at home.
Regulators in Europe and elsewhere are concerned about a similar problem with another coronavirus vaccine, developed by AstraZeneca And Oxford University researchers. This vaccine is not approved for emergency use in the United States.
Rebecca Robins, Jill Cowan, Dennis Grady, Karl Zimmer and Sharon Uterman contributed to this report.